Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    31-August-2000      
Issue 140 Next Update - 14:00 UTC 08:00 EST    01-September-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Back To Vidyya Today In Vidyyasm

Newsletter Summary For 31-August-2000:

NIH researchers have found pore-like holes in the membranes of red blood cells infected by the deadliest form of the malaria parasite. That parasite, Plasmodium falciparum, apparently uses these holes to supply itself with the nutrients it needs to grow and reproduce. The discovery may lead to the development of new treatments for malaria, a widespread and devastating disease.

In other news, the FDA is alerting health professionals to the potential for injury from two commonly used circumcision clamps, the Gomco®/gomco-type and Mogen®/mogen-type clamps. Both are widely used during circumcision to remove the foreskin while protecting the glans penis. We have recommendations from the FDA on how to avoid the device related problems in this issue. As a public service, Vidyya invites its readers to circulate the information without worry regarding copyright issues.

New research from National Institute of Mental Health (NIMH) suggests that women who suffer depression as they enter the early stages of menopause (perimenopause) may find estrogen to be an alternative to traditional antidepressants. The efficacy of the female hormone was comparable to that usually reported with antidepressants in the first controlled study of its direct effects on mood in perimenopausal women meeting standardized criteria for depression. The hormone has not been found to alleviate depression in postmenopausal patients. The NIMH has also updated their publication "Depression: What Every Woman Should Know." You'll find the patient education brochure in today's Vidyya.

Finally, the debate regarding hormone replacement therapy and heart disease is continuing. New research from the PHASE trial was presented this week at the 22nd Congress of the European Society of Cardiology. You can read a summary of findings that are in agreement with those from the HERS trial--HRT does not exhibit cardioprotective benefits in women with existing heart disease.

The articles in today's Vidyya are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.